New England Journal of Medicine · 2011 · 74 citations · 3 references
MedicineFamily MedicinePreventive MedicineCancer ScreeningMen's HealthPrimary CarePopulation ScreeningPreventive CarePreventive Care For MenPreventive Health CareScreeningScreening EvaluationDisease ScreeningPreventive Screening In MenProstate-specific Antigen Screening Controversy
Evidence of a possible small benefit from PSA screening supports a grade C recommendation — not the U.S. Preventive Services Task Force's proposed grade D — for men 55 to 69 years of age, who should participate in screening decisions after discussion with a primary care provider.
3
Prostate Cancer Screening Decisions
Richard M. Hoffman, Mick P. Couper, Brian J. Zikmund‐Fisher et al. · Archives of Internal Medicine · 2009 · 137 citations · Full text